ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Discovery of Orally Available Retinoic Acid Receptor-Related Orphan Receptor γ-t/Dihydroorotate Dehydrogenase Dual Inhibitors for the Treatment of Refractory Inflammatory Bowel Disease

Chen, Ji-An; Ma, Hui; Liu, Zehui; Tian, Jinlong; Lu, Sisi; Fang, Wenqing; Ze, Shuyin; Lu, Weiqiang; Xie, Qiong*; Huang, Jin*; Wang, Yonghui*复旦大学; 华东理工大学
Journal of Medicinal Chemistry2022-1-13DOI: 10.1021/acs.jmedchem.1c01746
4被引10阅读
引用收藏
分享

摘要

Inflammatory bowel disease (IBD) is a multifactorial autoimmune disease, representing a major clinical challenge. Herein, a strategy of dual-targeting approach employing retinoic acid receptor-related orphan receptor gamma-t (ROR gamma t) and dihydroorotate dehydrogenase (DHODH) was proposed for the treatment of IBD. Dual ROR gamma t/DHODH inhibitors are expected not only to reduce ROR gamma t-driven Th17 cell differentiation but also to mitigate the expansion and activation of T cells, which may enhance anti-inflammatory effects. Starting from 2-aminobenzothiazole hit 1, a series of 2-aminotetrahydrobenzothiazoles were discovered as potent dual ROR gamma t/DHODH inhibitors. Compound 14d stands out with IC50 values of 0.110 mu M for ROR gamma t and of 0.297 mu M for DHODH. With acceptable mouse pharmacokinetic profiles, 14d exhibited remarkable in vivo anti-inflammatory activity and dose-dependently alleviated the severity of dextran sulfate sodium (DSS)-induced acute colitis in mice. Taken together, the present study provides a novel framework for the development of therapeutic agents for the treatment of IBD.

学科与关键词

关键词
NUCLEAR RECEPTORCELLSCANCERIBD
相关
加载中…
  • Treatment with butyrate alleviates dextran sulfate sodium and Clostridium difficile-induced colitis by preventing activity of Th17 cells via regulation of SIRT1/mTOR in mice
    Wang, Siqi; Deng, Wenlin; Li, Fang; Xiang, Leyang; Lv, Pinjing; Chen, Ye*Journal of Nutritional Biochemistry, 2023, 111: 109155.被引 9
  • Discovery of novel 2-aryl-4-bis-amide imidazoles (ABAI) as anti-inflammatory agents for the treatment of inflammatory bowel diseases
    Li, Ling; Yuan, Sijie; Lin, Lin; Yang, Fang; Liu, Ting; Xu, Chenglong; Zhao, Huiting; Chen, Jingxuan; Kuang, Peihua; Chen, Ting*; Liao, Wenzhen*; Chen, JianjunBioorganic Chemistry, 2022, 120: 105619.被引 3
  • Discovery of novel 3-hydroxyandrosta-5,7-Diene-17-Carboxylic acid derivatives as anti-inflammatory bowel diseases (IBD) agents
    Chen, Jingxuan; Li, Ling; Liu, Jin; Yuan, Sijie; Liao, Wenzhen; Slominski, Andrzej T.; Li, Wei; Zmijewski, Michal A.; Chen, JianjunEuropean Journal of Medicinal Chemistry, 2021, 220: 113468.被引 7
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Medicinal Chemistry
发表日期
2022-01-13
卷期
第 65 卷, 第 1 期
页码
592-615
DOI
10.1021/acs.jmedchem.1c01746
语言
ENGLISH
期刊等级
1区
成果收录
SCIE
资助标注
National Science Foundation of China [81973163, 81874287, 82003577, 81973362, 81972828, 82173857]; Natural Science Foundation of Shanghai [19ZR1436700]; National Science and Technology Major Project [2018ZX09711002-003-014]; Shanghai Biopharmaceutical and Technology Supporting Plan [19431900100]; Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism (Shanghai Municipal Education Commission) [2021 Sci Tech 03-28]

作者

  • C

    Chen, Ji-An (第一作者)

    fudan univ

  • M

    Ma, Hui

    east china univ sci & technol

查看全部 11 位作者收起作者
  • L

    Liu, Zehui

    east china univ sci & technol

  • T

    Tian, Jinlong

    fudan univ

  • L

    Lu, Sisi

    east china univ sci & technol

  • F

    Fang, Wenqing

    east china univ sci & technol

  • Z

    Ze, Shuyin

  • L

    Lu, Weiqiang

  • X

    Xie, Qiong (通讯)

    fudan univ

  • H

    Huang, Jin (通讯)

    east china univ sci & technol

  • W

    Wang, Yonghui (通讯)

    fudan univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417